Thyroid function and dysfunction have largely been understood in hormonal and immunological terms.' Somatostatin has been described in scanty numbers of parafollicular cells,2 in one and the same cells as those known to produce calcitonin,3 and in medullary thyroid carcinoma.4 Somatostatin reduces TSH stimulated synthesis or release of T3 and T4.5 These authors suggested a physiological role for somatostatin in the regulation of thyroid metabolism. A role for somatostatin has not yet been considered in thyroid dysfunctional states where by its inhibitory influence it may play a part in hypothyroidism.
Hashimoto's thyroiditis encompasses a variety of clinical and histological features. Diagnosis depends upon serologically expressed immunological factors; cell-mediated factors, perhaps being more important in pathogenesis.6 Usually the disease presents as a painless diffuse goitre in young and middle-aged women and is often associated with hypothyroidism. The thyroid gland tends to be rubbery, firm and lobulated. A prominent nodule may provoke a suspicion of malignancy, local pressure symptoms or cosmetic indications for thyroidectomy may be present.7 In this way specimens of Hashimoto' s thyroiditis, amongst the causes of hypothyroidism, are most often available for study.
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One case which showed numerous cells forming small acini and staining for both NSE and somatostatin was examined in the electron microscope. Cells containing numerous weakly to moderately osmiophilic membrane bound granules 230-430 nm in diameter were found (Fig. 3) .
The pre-operative thyroid functional status corresponding to each of this series of cases is summarised in Tables 1-4 .I".. Hashimoto's thyroiditis (same case as Fig. 1 In our series of cases of Hashimoto's thyroiditis a remarkable number of cells with NSE and somatostatin-like immunoreactivity were demonstrated. There are no previous reports of such numbers of somatostatin-containing cells, in excess of calcitonin-containing cells, in the thyroid gland. Neurone specific enolase and somatostatin containing cells were seen in interfollicular and follicular locations and forming small acini. A nodular pattern was often seen.
Of 18 cases studied, four showed large numbers of somatostatin and NSE-containing cells, five showed moderate numbers, five showed occasional cells and four showed none. Staining for calcitonin showed few or no positive cells in any one of the cases.
Electron microscopy confirmed that cells, corresponding to those staining for NSE and somatostatin, contained variable numbers of large D type granules, similar to those which characterise somatostatin-containing cells of the pancreatic islets. The effect of somatostatin on thyroid iodine turnover in euthyroid volunteers was studied by Loos et al-. Their results suggest that somatostatin blocks TSH effect at the level of thyroid hormone synthesis or release, and experiments on isolated thyroid cells showed that somatostatin acts directly on these cells.'" These results are summarised in Table 5 , and compared with other studies of iodine metabolism in Hashimoto's disease. '6-'9 The data are difficult to compare and evaluate and present some discrepancies. In some cases of Hashimoto's disease increased iodine turnover is found, whereas somatostatin administered to TSH stimulated euthyroid volunteers "completely inhibits" iodine turnover.20 However, in both Hashimoto's disease and somatostatin-treated euthyroid volunteers stimulated with TSH there is inhibition of synthesis or release of thyroid hormone and inefficient iodine utilisation, while iodine uptake by the thyroid remains high.
In our series, no obvious firm correlation emerged between a hypothyroid state at the time of operation and the number of cells staining positively for NSE and somatostatin (Tables 1-4 It is hazardous to attempt to deduce hormonal status from morphological assumptions of endocrine activity and it is not surprising therefore, in an issue as complex as function of diseased and treated thyroid glands, that no straightforward conclusions are forthcoming.
Hashimoto's thyroiditis is associated with other organ-specific immune diseases.6 It would be interesting to investigate the possibility that paracrine influences including somatostatin contribute to the pathogenesis of diseases such as Grave's disease and pernicious anaemia. Somatostatin is found ordinarily within paracrine cells of the thyroid gland. In conditions of thyroid functional excess it may serve normally as a local inhibiting "neuroparacrine" effector, balancing other modulating mechanisms which act by thyroid stimulation. It is possible that paracrine influences contribute to the diversity of thyroid function and histological appearance seen in Hashimoto's disease. The presence of extraordinary numbers of cells containing somatostatin, an inhibitory substance, inappropriate in a condition tending towards hypothyroidism and the effects of which are broadly comparable to the metabolic state of Hashimoto's disease, suggests to us that a paracrine contribution to the hypothyroidism of this condition is likely.
